Correction to: Therapeutic benefits of niraparib tosylate as radio sensitizer in esophageal squamous cell carcinoma: an in vivo and in vitro preclinical study

被引:0
|
作者
Yuzhong Cui
Wei Huang
Feng Du
Xiaoyang Yin
Lei Feng
Baosheng Li
机构
[1] Tianjin Medical University Cancer Institute and Hospital,Department of Oncology
[2] National Clinical Research Center for Cancer,Department of Radiation Oncology, Shandong Cancer Hospital and Institute
[3] Key Laboratory of Cancer Prevention and Therapy,undefined
[4] Tianjin’s Clinical Research Center for Cancer,undefined
[5] Zibo Municipal Hospital,undefined
[6] Shandong First Medical University and Shandong Academy of Medical Sciences,undefined
[7] Shandong First Medical University and Shandong Academy of Medical Sciences,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:560 / 562
页数:2
相关论文
共 50 条
  • [31] Cirsiliol targets tyrosine kinase 2 to inhibit esophageal squamous cell carcinoma growth in vitro and in vivo
    Jia, Xuechao
    Huang, Chuntian
    Hu, Yamei
    Wu, Qiong
    Liu, Fangfang
    Nie, Wenna
    Chen, Hanyong
    Li, Xiang
    Dong, Zigang
    Liu, Kangdong
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)
  • [32] Nuplazid suppresses esophageal squamous cell carcinoma growth in vitro and in vivo by targeting PAK4
    Yaxing Wei
    Wenjie Wu
    Yanan Jiang
    Hao Zhou
    Yin Yu
    Lili Zhao
    Xiangyu Wu
    Xuebo Lu
    Qiang Yuan
    Zitong Wang
    Zigang Dong
    Luyun He
    Jimin Zhao
    Kangdong Liu
    British Journal of Cancer, 2022, 126 : 1037 - 1046
  • [33] Periplogenin suppresses the growth of esophageal squamous cell carcinoma in vitro and in vivo by targeting STAT3
    Yamei Hu
    Fangfang Liu
    Xuechao Jia
    Penglei Wang
    Tingxuan Gu
    Hui Liu
    Tingting Liu
    Huifang Wei
    Hanyong Chen
    Jiuzhou Zhao
    Ran Yang
    Yingying Chen
    Zigang Dong
    Kangdong Liu
    Oncogene, 2021, 40 : 3942 - 3958
  • [34] Adenovirus-mediated RhoA shRNA suppresses growth of esophageal squamous cell carcinoma cells in vitro and in vivo
    Ji Ma
    Jian Zhang
    Yuguang Ma
    Jin Zheng
    Yuanxiong Cheng
    Yan Xue
    Wenchao Liu
    Medical Oncology, 2012, 29 : 119 - 126
  • [35] Dasabuvir suppresses esophageal squamous cell carcinoma growth in vitro and in vivo through targeting ROCK1
    Liu, Xinning
    Jiang, Yanan
    Zhou, Hao
    Zhao, Xiaokun
    Li, Mingzhu
    Bao, Zhuo
    Wang, Zitong
    Zhang, Chenyang
    Xie, Zhenliang
    Zhao, Jimin
    Dong, Zigang
    Liu, Kangdong
    Guo, Zhiping
    CELL DEATH & DISEASE, 2023, 14 (02)
  • [36] Bufadienolides induce p53-mediated apoptosis in esophageal squamous cell carcinoma cells in vitro and in vivo
    Lin, Shaohuan
    Lv, Junhong
    Peng, Panli
    Cai, Changqing
    Deng, Jianming
    Deng, Haihong
    Li, Xuejun
    Tang, Xinyue
    ONCOLOGY LETTERS, 2018, 15 (02) : 1566 - 1572
  • [37] Adenovirus-mediated RhoA shRNA suppresses growth of esophageal squamous cell carcinoma cells in vitro and in vivo
    Ma, Ji
    Zhang, Jian
    Ma, Yuguang
    Zheng, Jin
    Cheng, Yuanxiong
    Xue, Yan
    Liu, Wenchao
    MEDICAL ONCOLOGY, 2012, 29 (01) : 119 - 126
  • [38] Targeting CAFs-Secreted TGFβ1 Signaling to Radiosensitize Esophageal Squamous Cell Carcinoma In Vitro and In Vivo
    Zhang, H.
    Yue, J.
    Jiang, Z.
    Wu, H.
    Zhang, X.
    Yang, L.
    Jiang, M.
    Hua, Y.
    Li, Y.
    Huang, M.
    Hou, Q.
    Li, W.
    Wu, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S149 - S149
  • [39] Azelnidipine inhibits esophageal squamous cell carcinoma proliferation in vivo and in vitro by targeting MEK1/2
    Zhao, Lili
    Zhang, Yuhan
    Li, Ang
    Lu, Xuebo
    Li, Mingzhu
    Yuan, Qiang
    Yang, Ning
    Zhao, Xiaokun
    Li, Xin
    Jiang, Yanan
    Liu, Kangdong
    MOLECULAR THERAPY ONCOLYTICS, 2022, 27 : 61 - 72
  • [40] Targeting MUC1-C reverses the cisplatin resistance of esophageal squamous cell carcinoma in vitro and in vivo
    Zhao, Yong-Qiang
    Wu, Ting
    Wang, Li-Feng
    Yin, Bo
    Shi, Mo
    Jiang, Bin
    Gong-Sun, Xin
    Song, Xue-Min
    Liu, Xiang-Yan
    TRANSLATIONAL CANCER RESEARCH, 2021, 10 (02) : 645 - 655